Inhalable biologics: Serendex formulates with Novozymes’ Recombumin
Serendex Pharmaceutical is a step closer to developing an inhalable biopharmaceutical for lung disease after adopting stabilising tech from Novozymes.
Archives for May 19, 2015
Celltrion presents data at US conference
Celltrion’s Remsima campaign rolled into the US this week with another presentation of data showing that the Remicade (Infliximab) biosimilar is equivalent to the reference drug.
Medicago plants $245m seed for plant-based vaccine plant
Medicago has ploughed $245m into an influenza vaccine plant that will use a tobacco-based technology it says produces high yields quicker than with egg-based platforms.